Doctors may soon have a new tool to spot heart attack risks faster. A small ECG device, about the size of a credit card, could help predict heart attacks before symptoms get serious. In a study, researchers tested it on 184 patients with chest pain. The device, used with an algorithm, correctly iden
Encora Therapeutics has earned FDA approval for its wrist‑sized device, the Encora X1, which can be prescribed to adults who suffer from essential tremor. The clearance means the product can now be sold in the United States for this specific use. Clinical data from two trials support the decision.
Inspira Technologies is making a bold step into the cancer diagnostics field. They've signed a preliminary deal to buy a company that specializes in liquid biopsy technology. This tech can detect cancer cells in blood samples using AI. The deal also includes a $15 million investment from an unnamed
